Perbedaan Estee Gold Feet Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Estee Gold Feet Tbk. diperdagangkan di Rp1.400 (kapitalisasi pasar 3,68 T, volume 24 jam 168,3 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Estee Gold Feet Tbk. jauh lebih besar — sekitar 22,2× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (324 rb vs 168,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| EURO | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 3,68 T | 166,01 M |
Volume | 168,3 rb | 324 rb |
Lot | 1,68 rb | 3,24 rb |
Perputaran | 233,12 jt | 77,68 jt |
Harga Rata-rata | 1.385,12 | 239,75 |
Nilai Transaksi | 233,12 jt | 77,68 jt |
Harga Ekuilibrium Indikatif | 1.400 | 240 |
Volume Ekuilibrium Indikatif | 71 | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Estee Gold Feet Tbk (Company) was established by Notarial Deed No. 32 dated January 21, 1980 from Abdoel Sjoekoer, S.H., Notary in Jakarta. The Company started its commercial operations in 1986. The Company is controlled by its immediate parent company, PT Timmsvale, a company domiciled in Indonesia. The ultimate beneficial owners of the Company are Johansen Ngian.
Selengkapnya di halaman EURO →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →